Close view of suramin #2 overlapped with RNA primer strand. This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication.

Suramin is not approved to treat ASD by the U.S. Food and Drug Administration, and the drug is not commercially available. Naviaux has filed a patent application related to antipurinergic ...

Suramin, a medication generally used to treat African sleeping sickness and river blindness, is not approved by the U.S. Food & Drug Administration (FDA) for any use, and the preliminary studies ...

Emergent shortages of the drug used to treat the most severe form of African sleeping sickness creates immediate need for direct access to the global drug market for affected nationsAs previously ...

The request seeks emergency access to the Company’s recently completed registration batches of PAX-101 (IV suramin) to address the critical shortage of medications required to combat the life ...

We are dedicated to the continuous development and evaluation of our pioneering program, PAX-101, an intravenous suramin formulation that lies at the heart of our efforts, ...

PaxMedica's suramin treatment for ASD gains spotlight in analyst report ...

Suramin Medication Information. Learn everything you need to know about Suramin-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it.

TARRYTOWN, New York, Oct. 31, 2023 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica, Inc. (Nasdaq: PXMD), a pioneering biopharmaceutical company specializing in cutting-edge treatments for neurological ...